PPT-English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR)

Figures Slideset The 5year UK AMR strategy Key aims improving infection prevention and control practices optimising prescribing practices improving professional education training and public engagement. GUNA Summer Clinical Meeting . 28. th. June 2013. Antibiotic resistance in . Neisseria gonorrhoeae. Today’s prese. nta. tion. Overview of gonorrhoea. Disease. UK surveillance data. Antibiotic resistance. N. gonorrhoeae. . A Review. INTRODUCTION. Progressive antimicrobial resistance in . Neisseria gonorrhoeae . is an emerging public health threat. The Public Health Agency of Canada (the Agency) released updated recommendations in July 2013 for the diagnosis, treatment, follow-up and reporting of gonorrhea. Director, The National Antimicrobial Resistance Monitoring System. U.S. Food & Drug Administration. Center for Veterinary Medicine . Office of Research. Laurel, MD USA. The National Antimicrobial Resistance Monitoring System. . Dr Andrea Ammon, ECDC Director, . 27 June 2017, European Parliament. 0. 200. 400. 600. 800. 1000. 1900. 1920. 1940. 1960. 1980. 2000. 1918. Influenza pandemic. 1924. Plague: last human-to-human transmission. Director, The National Antimicrobial Resistance Monitoring System. U.S. Food & Drug Administration. Center for Veterinary Medicine . Office of Research. Laurel, MD USA. The National Antimicrobial Resistance Monitoring System. (2011 – 2020). &. Global action plan on AMR . (2015). Dr Danilo Lo Fo . Wong. Programme Manager AMR. WHO Regional Office for Europe. WHO efforts on antimicrobial resistance. 2014. 2015. 2001. 2003. a pharmaceutical industry perspective. 17. th. November 2018. Dr Bryan Deane. Dept of Research, Medical & Innovation . Introduction – the ABPI; the biopharmaceutical industry. AMR: the issue. 26. th. February 2018. Call topic identification for 2019 call. JPIAMR Calls to date…. 2014 Therapeutics: . InnovaResistance. : Innovative approaches to address antibacterial . resistance. 2015 Therapeutics. (2011 – 2020). &. Global action plan on AMR . (2015). Dr Danilo Lo Fo . Wong. Programme Manager AMR. WHO Regional Office for Europe. WHO efforts on antimicrobial resistance. 2014. 2015. 2001. 2003. –. . AURA 2017. Professor John Turnidge . Senior Medical Advisor. #2017AURA. The AURA Surveillance System – 2017. Surveillance of antimicrobial use and resistance in hospitals and the community (including aged care homes. Consequences of AMR. What can we do ?. Microbiology and the antibiotic apocalypse. Dr Dave Whitworth. dew@aber.ac.uk. Reader in Biochemistry. Microbiology and the antibiotic apocalypse. What are antibiotics ?. Resistance : T ackling a crisis for the health and wealth of nations The Review on Antimicrobial Resistance Chaired by Jim O’Neill December 2014 Contents What is antimicrobial resistance? RESISTANCE Interagency Task Force on Antimicrobial Resistance Co - Chairs: Centers for Disease Control and Prevention Food and Drug Administration National Institutes of Health Participating Agencie s 1. 1. Antibacterial resistance in ophthalmic infections: a multi-centre analysis across UK care settings//BMC Infectious Diseases.- volume 19, Article number: 768 (2019) . Educational MODULE. November 2020.